S2N.Bio commences technology transfer of Alzheimer’s cell therapy to Cell Therapies’ Melbourne GMP facility

by rss feed | Oct 20, 2026 | News Feeds

Cell Therapies Pty Ltd and S2N.Bio (“S2N”) have commenced technology transfer of S2N’s cell therapy candidate for Alzheimer’s disease. The transfer will enable GMP manufacture of clinical trial material for S2N’s first-in-human study in Australia. Read Original...

Discovery of new bacteria opens fresh avenues for prostate cancer research

by rss feed | Oct 20, 2026 | News Feeds

​University of East Anglia researchers have discovered the genetic blueprints of 18 new bacterial species collected from prostate cancer patients. Read Original...

Advanced AI tool estimates biological age and predicts cancer survival from face photos

by rss feed | Oct 20, 2026 | News Feeds

Researchers are using AI tools to analyze simple facial photographs to determine key indicators of a person's health. Mass General Brigham researchers built FAHR-Face (Foundation Artificial Intelligence for Health Recognition), a large AI foundation model trained on...

Not all ultra-processed foods show the same cancer risk

by rss feed | Oct 20, 2026 | News Feeds

Ultra-processed foods show varied associations with colorectal cancer, underscoring the need for precise research on diet quality and cancer risk factors. Read Original...

New AI model detects hidden diseases in routine CT scans

by rss feed | Oct 20, 2026 | News Feeds

When analyzed by a new artificial intelligence model developed at Penn Medicine, CT scans reveal much about a patient's health beyond the specific condition they were originally ordered for, according to a new study published in NPJ Digital Medicine. Read Original...